Victoza Cost in 2026: Price, Coupons, and Savings Paths

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Victoza (liraglutide) is one of the most-searched GLP-1 medications in the U.S. as of April 2026, and cost questions come up constantly. What a patient pays depends on far more than the sticker figure. This guide separates list price from real-world cost and the levers that move it. The PlexusDx Education Hub links to related pricing guides.

The published list price

Victoza list price is approximately $815 per month at U.S. list price as of April 2026, based on Novo Nordisk published pricing. That number is the starting point, not the destination: out-of-pocket cost varies with insurance coverage, the FDA-approved indication for which the prescription is written, manufacturer savings programs, and the pharmacy where it is filled. List price is rarely what most insured patients actually pay.

Insurance and coverage notes

Coverage for Victoza hinges on whether the prescription is for an FDA-approved indication and on the specific plan formulary. Many commercial plans cover liraglutide for type 2 diabetes, while coverage for chronic weight management is more variable and often subject to prior authorization or BMI-based criteria. Because plan terms change, checking directly with your plan as of April 2026 is the only reliable way to know your number.

Why the indication on the script matters

The same molecule can be covered for one indication and excluded for another, so the reason a prescription is written affects the price you see. That is a coverage-logic issue, not a clinical one.

Savings cards and pharmacy coupons

Novo Nordisk publishes a manufacturer savings card program that, for eligible commercially-insured patients, can substantially reduce monthly out-of-pocket cost. Independent pharmacy discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy. Eligibility and savings amounts change over time, so verify on the manufacturer website or with your pharmacy at the time of fill rather than relying on a figure quoted online.

Where compounded options fit

Compounded alternatives prepared by licensed 503A pharmacies are another path some patients explore, priced separately from the FDA-approved brand. Compounded products are legally and factually different from brand products — not generics — and any decision about them belongs with a qualified clinician.

Why the quoted number is rarely your number

The gap between list price and what a patient pays is the whole story of GLP-1 cost. Rebates, formulary placement, prior authorization, savings-card eligibility, and the specific pharmacy all sit between the $815 headline and the counter. Two people can fill the same prescription and pay very different amounts on the same day.

That is why any figure quoted online should be treated as a reference point, not a quote. The reliable move is to confirm coverage for the exact indication on the prescription, check current savings-card terms at the time of fill, and compare pharmacy pricing. Those steps do more to change the final number than the list price itself ever will.

The genetics before the spend

Upstream of any GLP-1 protocol decision, the PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in FTO, GLP1R, and MC4R — that shape baseline GLP-1, appetite-regulation, and energy-balance biology. It offers pathway-level context and does not predict response to any specific medication. Review the Precision Peptide Genetic Test, and browse the Weight Management Protocols collection. PlexusDx does not sell, prescribe, or recommend liraglutide or other therapeutic peptides in this category.

The takeaway on Victoza cost

The $815 list figure is the beginning of the cost story, not the end. Coverage, the indication on the prescription, savings cards, pharmacy pricing, and compounded options all reshape what you actually pay. Verifying each of those at the time of fill is the reliable way to turn an online estimate into a real number for your situation. Because eligibility and terms change over time, the figure that applied last month may not apply today, which is why the verification step matters more than any single quote you find. Treat every published price as provisional until your pharmacy confirms it.

Frequently Asked Questions

How much does Victoza cost without insurance?

Victoza list price is approximately $815 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. Without insurance and without a manufacturer savings card, that list figure is roughly what cash-pay patients face at most U.S. pharmacies. Savings programs and pharmacy coupons can reduce it.

Is there a coupon or savings card for Victoza?

Yes. Novo Nordisk publishes a manufacturer savings card for eligible commercially-insured patients that can substantially reduce monthly out-of-pocket cost. Independent platforms like GoodRx and SingleCare also publish discounted prices that vary by pharmacy and change frequently. Verify eligibility at the time of fill.

Why is Victoza expensive?

Victoza is a patent-protected branded medication, and Novo Nordisk sets list price based on R&D cost recovery, market positioning, and expected payer mix. Prices have stayed high in part because demand outpaced manufacturing in 2023 and 2024. Savings programs and compounded alternatives are the main levers patients use.

Are compounded versions cheaper?

Often yes. Compounded liraglutide prepared by licensed 503A pharmacies has historically been priced below Victoza list price. The trade-offs are regulatory complexity, variability in prescriber oversight, and the FDA's evolving stance on compounding pathways. Discuss the specifics with a qualified clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.